Everpure's Q2 Earnings Hide a Cash Flow Problem the Stock Already Prices In

Everpure reported $1.19 billion in revenue, up 38% year-over-year. Adjusted earnings per share of $0.70 beat the $0.58 consensus. Management raised full-year revenue guidance to $5.03 billion–$5.07 billion, and lifted operating profit guidance to $940 million–$960 million. It looked like another flawless quarter for a company riding the AI storage wave.

The numbers above the line are real. But look one level deeper into the cash flow statement and the story shifts.

Operating cash flow turned negative at minus $136 million. Both were positive in the prior year quarter, and the reversal is not a small miss — it is a structural signal about what's happening beneath the revenue acceleration.

Here is why it matters and what it means for anyone watching this stock.

The Supply Chain Scramble

The cash flow collapse came from one dominant source: Everpure spent $577 million on prepaid expenses and other assets, up from roughly $14 million in the comparable prior-year period. A 40-fold increase in a single quarter.

Management described it as a scramble to secure NAND flash memory and other components. Industry-wide demand for AI infrastructure has created supply constraints, and Everpure — like other hardware companies in this space — is paying large upfront premiums to lock in capacity. The company's total cash balance fell from $1.5 billion at the end of Q1 to about $1.0 billion.

This is not normal growth. Healthy revenue acceleration should come with improving cash conversion, not a massive working capital bleed. When a company has to prepay suppliers hundreds of millions of dollars to fulfill its own orders, it means the supply chain is the bottleneck, not demand. The headline says 38% growth. The cash flow says they are buying that growth with their balance sheet.

The Margin Illusion

The income statement tells a parallel story. Non-GAAP operating income of $230 million looks strong — a 19.4% margin. But GAAP operating income was $63 million, a 5.3% margin, because stock-based compensation surged 36% year-over-year to $160 million. That is not a rounding difference. Stock-based compensation is a real cost — it is the price paid to attract and retain talent in a competitive market.

Gross margin also compressed slightly, from roughly 70% a year ago to 68.4% on a GAAP basis. Management passed along some cost increases to customers, but not all of them. The gross margin tells you that the supply chain squeeze is real; the cash flow tells you the timing of that squeeze has not yet passed.

The Valuation Problem

This is where the analysis moves from accounting to investment judgment. Everpure trades at a $36 billion market capitalization. That works out to roughly 9 times trailing sales and nearly 70 times trailing free cash flow of about $516 million. On the raised full-year guidance of $5 billion, the stock is pricing in roughly 7 times forward revenue — a multiple that assumes the growth keeps accelerating and the cash flow recovers. Forward earnings multiples are even more stretched.

The stock is up 62% year-to-date and nearly 43% over the past rolling year. It has climbed from a 52-week low of $56.78 to trade near $109 today. Even after beating Q2 estimates by a wide margin and raising guidance, the stock dipped 1.7% in after-hours trading. The market gave the good numbers a glance and kept pricing the same risk: what if the cash intensity does not improve?

This is not a beaten-down name where the market has given up and the numbers quietly improve underneath. That is the setup I look for. This is a stock where the market is already optimistic, the multiple is rich, and the cash flow has just broken at the worst possible time.

The Proof Path Forward

I am not saying Everpure is a bad business. The growth is real — 38% revenue growth for eight straight accelerating quarters is not an accident. The second top-five hyperscaler design win validates the DirectFlash architecture strategy. The $2.1 billion in subscription annual recurring revenue provides a stable floor.

But the investment case at this price depends entirely on one thing: cash flow recovery. The company must prove that the supply chain prepayments are a temporary working capital hit, not a structural cost of doing business. Over the next two quarters, the $577 million in prepayments should begin converting into delivered product and collected revenue, reversing the working capital drag and restoring free cash flow.

If that happens — if Q3 and Q4 show operating cash flow returning to positive territory and free cash flow rebounding toward the $100 million+ per quarter range that characterized much of last year — the growth story can sustain this valuation. The revenue trajectory would justify it.

If it does not — if working capital continues to consume cash, if NAND supply remains tight through 2027, or if the company needs to keep prepaying to meet its own raised guidance — the valuation becomes unsustainable. A $36 billion market cap with a quarter of negative free cash flow and $577 million in supplier prepayments leaves no room for the growth story to be financed by balance sheet depletion.

The guidance raise to $5 billion plus for full-year revenue makes this even more important. Meeting that number requires flawless execution through the rest of fiscal 2027. The Q4 implied run-rate of roughly $1.48 billion is the biggest quarter in company history. That is ambitious guidance, and ambitious guidance backed by negative free cash flow is a combination that investors should watch carefully.

What to Watch

The next earnings report in November will be the first real test. Look for operating cash flow to turn positive again. Look for prepaid expenses to decline from the $577 million spike. Look for free cash flow to recover toward last year's quarterly run-rate. The revenue and earnings numbers will almost certainly be strong — the question is whether cash follows.

Everpure is building a real business with real momentum. The problem is not the business — it is the price. At nearly $36 billion in market value, the stock already assumes the supply chain problem resolves, the cash flow rebounds, and every raised guidance target is met. That is a lot of assumptions to carry in one number. The cash flow over the next two quarters will tell you whether those assumptions hold up or whether the market needs to rethink what it is paying for.